Dr. S surely will be the main man and Mr. Christopher Turner may be the man in charge to marketing the GKG & cosmetics. (SEE Below.)
Mr. Chang may be the man for Japan, China, Southeast Asia and Mr. Arshad for India & Pakistan. (to include cosmetics)
What do you think??
“The cosmetics industry has a global sales volume of $300 billion per year and is growing at 4.5% per year. Europe and the US represent the bulk of sales, but the fastest growth is in Japan, China, Southeast Asia and India. When I started Elite Therapeutics, my goal was to create and grow a physician-driven, luxury-niche cosmetics company with a value in the $100-$400 million range in 10-12 years. When I became Chairman of the Board of Directors of VIASPACE, my goal for VIASPACE was to grow it into a global biomass, bioenergy and animal feed company with an ultimate value in the $500 million range. I see synergy and security in a combined company dedicated to grow stronger, faster and to create revenues, cash flow and shareholder value. Our combined product lines of bioenergy and cosmetics are both global in reach.”
Elite Therapeutics CEO, Mr. Christopher Turner, commented, “I have worked for Elite Therapeutics since 2009 and am a long-term VIASPACE shareholder. I fully support examining the overall potential of combining these two companies. We use plastic containers for nearly all our products and I could see having a plastic container manufacturing site powered by Giant King Grass generated electricity and creating plastic containers derived from GKG plant-based plastics. I spend nearly half my time in California and am willing to assist Dr. Kukkonen in responding to potential new VIASPACE clients as we seek to grow a combined company. I see many possible financial and business outreach advantages to both companies if they chose to combine forces.”
